TOX Acts as a Tumor Suppressor by Inhibiting mTOR Signaling in Colorectal Cancer

The treatment and prognosis of advanced colorectal cancer (CRC) remain a challenging clinical research focus. Here, we describe a new CRC tumor suppressor and potential therapeutic target: thymocyte selection associated high mobility group box (TOX) protein. The expression of TOX was lower in CRC th...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Mengdi, Huang, Qianru, Li, Changcan, Jiang, Zhiyuan, Sun, Jing, Wang, Zhiyu, Liang, Rui, Li, Dan, Li, Bin, Zhao, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062716/
https://www.ncbi.nlm.nih.gov/pubmed/33897695
http://dx.doi.org/10.3389/fimmu.2021.647540

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062716/
https://www.ncbi.nlm.nih.gov/pubmed/33897695
http://dx.doi.org/10.3389/fimmu.2021.647540

Ejemplares similares